Clinical Trials Directory

Trials / Conditions / Maxillary Sinusitis

Maxillary Sinusitis

14 registered clinical trials studyying Maxillary Sinusitis — 2 currently recruiting.

StatusTrialSponsorPhase
UnknownAssessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position
NCT04903418
Cairo University—
RecruitingBalloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
NCT04645511
Tampere University HospitalN/A
UnknownEndoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis
NCT04241016
Oulu University HospitalN/A
RecruitingSingle-step Functional Sinus Endoscopy and Transoral Surgery
NCT06130176
Qassim UniversityN/A
UnknownEndosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis
NCT03083392
Western Galilee Hospital-NahariyaN/A
UnknownStudy Designed to Clinically Evaluate Sinus Wash Device Prototypes
NCT02931604
SinuSafe Medical LTDN/A
CompletedNon-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The E
NCT01032174
Pfizer—
CompletedMicroarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis
NCT00683371
University of California, San FranciscoN/A
TerminatedStudy to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis
NCT00245440
CPL AssociatesPhase 4
CompletedTrial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avel
NCT00668304
BayerPhase 4
CompletedA Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.
NCT00236652
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
CompletedA Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for
NCT00643409
PfizerPhase 3
CompletedAMS VS MOXI Ketek vs Avelox in AMS
NCT00537563
SanofiPhase 3
CompletedA Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the
NCT00249210
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3